Ropivacaine 75 mg versus placebo in perineal infiltration for analgesic efficacy at mid- and long-term for episiotomy repair in postpartum women - the ROPISIO study: a two-center, randomized, double-blind, placebo-controlled trials

Claire Cardaillac, Stéphane Ploteau, Aurélie Le Thuaut, Vincent Dochez, Norbert Winer, Guillaume Ducarme, Claire Cardaillac, Stéphane Ploteau, Aurélie Le Thuaut, Vincent Dochez, Norbert Winer, Guillaume Ducarme

Abstract

Background: Perineal pain due to episiotomy is commonly reported and can be severe enough to disturb the mother-infant dyad during the postpartum period. Its incidence at day 7 postpartum varies from 63% to 74%. Recent studies have investigated the analgesic efficacy of perineal infiltration of ropivacaine after episiotomy but have only focused on the immediate postpartum period (at 24 and 48 h after birth). Large, adequately powered, multicenter, randomized controlled trials are required to evaluate the impact of ropivacaine infiltration on perineal pain and mid- and long-term quality of life before the widespread use of ropivacaine to prevent perineal pain after episiotomy can be recommended.

Methods/design: The ROPISIO study is a two-center, randomized, double-blind, placebo-controlled trial being conducted in La Roche sur Yon and Nantes, France. It will involve 272 women with vaginal singleton delivery and mediolateral episiotomy at term (≥ 37 weeks). Perineal infiltration (ropivacaine 75 mg or placebo) will be administrated just after vaginal birth and before episiotomy repair. The primary outcome will be the analgesic efficacy at day 7 postpartum (midterm), defined by the Numeric Pain Rating Scale (NPRS) strictly superior to 3/10 on the perineal repair area. Secondary outcomes will be the analgesic efficacy (NPRS) and the impact of pain on daily behavior, on the quality of life (36-item Short Form Health Survey), on the occurrence of symptoms of postpartum depression (Edinburgh Postnatal Depression Scale), and on sexual health (Female Sexual Function Index) at 3 and 6 months (long-term) using validated online questionnaires. This study will have 90% power to show approximately 30% relative risk reduction in the incidence of perineal pain at day 7, from 70.0% to 50.0%.

Discussion: Ropivacaine is a promising candidate drug, inexpensive, and easy to administer, and it would be suitable to include in the routine management of deliveries in labor ward. This study will investigate if perineal ropivacaine infiltration just after birth can reduce mid- and long-term postpartum pain and increase quality of life in women with mediolateral episiotomy.

Trial registration: ClinicalTrials.gov, NCT03084549. Registered on 14 April 2017.

Keywords: Episiotomy; Local infiltration; Perineal pain; Ropivacaine.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figure. The figure shows the phases of the trial and data collection time points. DN4 Douleur Neuropathique 4, EPDS Edinburgh Postnatal Depression Scale, FSFI Female Sexual Function Index, SF-36 36-Item Short Form Health Survey

References

    1. Kettle C, Hills RK, Ismail KM. Continuous versus interrupted sutures for repair of episiotomy or second degree tears. Cochrane Database Syst Rev. 2007;4:CD000947. doi: 10.1002/14651858.CD000947.pub2.
    1. Boujenah J, Tigaizin A, Fermaut M, Murtada R, Benbara A, Benchimol M, Pharisien I, Carbillon L. Is episiotomy worthwhile to prevent obstetric anal sphincter injury during operative vaginal delivery in nulliparous women? Eur J Obstet Gynecol Reprod Biol. 2019;232:60–64.
    1. Carroli G, Mignini L. Episiotomy for vaginal birth. Cochrane Database Syst Rev. 2009;1:CD000081.
    1. Hartmann K, Viswanathan M, Palmieri R, Gartlehner G, Thorp J, Lohr KN. Outcomes of routine episiotomy: a systematic review. JAMA. 2005;293:2141–2148.
    1. Macarthur AJ, Macarthur C. Incidence, severity, and determinants of perineal pain after vaginal delivery: a prospective cohort study. Am J Obstet Gynecol. 2004;191:1199–1204.
    1. Klein MC, Gauthier RJ, Robbins JM, Kaczorowski J, Jorgensen SH, Franco ED, Johnson B, Waghorn K, Gelfand MM, Guralnick MS. Relationship of episiotomy to perineal trauma and morbidity, sexual dysfunction, and pelvic floor relaxation. Am J Obstet Gynecol. 1994;171:591–598.
    1. Manresa M, Pereda A, Bataller E, Terre-Rull C, Ismail KM, Webb SS. Incidence of perineal pain and dyspareunia following spontaneous vaginal birth: a systematic review and meta-analysis. Int Urogynecol J. 2019;30:853–868.
    1. Karbanova J, Rusavy Z, Betincova L, Jansova M, Necesalova P, Kalis V. Clinical evaluation of early postpartum pain and healing outcomes after mediolateral versus lateral episiotomy. Int J Gynecol Obstet. 2014;127:152–156.
    1. Declercq E, Cunningham DK, Johnson C, Sakala C. Mothers’ reports of postpartum pain associated with vaginal and cesarean deliveries: results of a national survey. Birth. 2008;35:16–24.
    1. Doğan B, Gün İ, Özdamar Ö, Yılmaz A, Muhçu M. Long-term impacts of vaginal birth with mediolateral episiotomy on sexual and pelvic dysfunction and perineal pain. J Matern Fetal Neonatal Med. 2017;30:457–460.
    1. Turmo M, Echevarria M, Rubio P, Almeida C. Development of chronic pain after episiotomy. Rev Esp Anestesiol Reanim. 2015;62:436–442.
    1. Eckerdal P, Georgakis MK, Kollia N, Wikström AK, Högberg U, Skalkidou A. Delineating the association between mode of delivery and postpartum depression symptoms: a longitudinal study. Acta Obstet Gynecol Scand. 2018;97:301–311.
    1. Le Strat Y, Dubertret C, Le Foll B. Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States. J Affect Disord. 2011;135:128–138.
    1. Swenson CW, DePorre JA, Haefner JK, Berger MB, Fenner DE. Postpartum depression screening and pelvic floor symptoms among women referred to a specialty postpartum perineal clinic. Am J Obstet Gynecol. 2018;218:335.
    1. Woolhouse H, Gartland D, Perlen S, Donath S, Brown SJ. Physical health after childbirth and maternal depression in the first 12 months post partum: results of an Australian nulliparous pregnancy cohort study. Midwifery. 2014;30:378–384.
    1. Chang SR, Chen KH, Lee CN, Shyu MK, Lin MI, Lin WA. Relationships between perineal pain and postpartum depressive symptoms: a prospective cohort study. Int J Nurs Stud. 2016;59:68–78.
    1. McDonald E, Gartland D, Small R, Brown S. Dyspareunia and childbirth: a prospective cohort study. BJOG Int J Obstet Gynaecol. 2015;122:672–679.
    1. Buhling KJ, Schmidt S, Robinson JN, Klapp C, Siebert G, Dudenhausen JW. Rate of dyspareunia after delivery in primiparae according to mode of delivery. Eur J Obstet Gynecol Reprod Biol. 2006;124:42–46.
    1. Signorello LB, Harlow BL, Chekos AK, Repke JT. Postpartum sexual functioning and its relationship to perineal trauma: a retrospective cohort study of primiparous women. Am J Obstet Gynecol. 2001;184:881–890.
    1. Beaussier M, Benhamou D. Guide de l’analgésie par infiltration. Montpellier: Sauramps médical; 2000.
    1. Nordin P, Zetterström H, Gunnarsson U, Nilsson E. Local, regional, or general anaesthesia in groin hernia repair: multicentre randomised trial. Lancet. 2003;362:853–858.
    1. Aasbø V, Thuen A, Raeder J. Improved long-lasting postoperative analgesia, recovery function and patient satisfaction after inguinal hernia repair with inguinal field block compared with general anesthesia. Acta Anaesthesiol Scand. 2002;46:674–678.
    1. Jebeles JA, Reilly JS, Gutierrez JF, Bradley EL, Kissin I. The effect of pre-incisional infiltration of tonsils with bupivacaine on the pain following tonsillectomy under general anesthesia. Pain. 1991;47:305–308.
    1. Eng HC, Ghosh SM, Chin KJ. Practical use of local anesthetics in regional anesthesia. Curr Opin Anaesthesiol. 2014;27:382–387.
    1. Akerman B, Hellberg IB, Trossvik C. Primary evaluation of the local anaesthetic properties of the amino amide agent ropivacaine (LEA 103) Acta Anaesthesiol Scand. 1988;32:571–578.
    1. Gutton C, Bellefleur JP, Puppo S, Brunet J, Antonini F, Leone M, Bretelle F. Lidocaine versus ropivacaine for perineal infiltration post-episiotomy. Int J Gynecol Obstet. 2013;122:33–36.
    1. Schinkel N, Colbus L, Soltner C, Parot-Schinkel E, Naar L, Fournié A, Granry JC, Beydon L. Perineal infiltration with lidocaine 1%, ropivacaine 0.75%, or placebo for episiotomy repair in parturients who received epidural labor analgesia: a double-blind randomized study. Int J Obstet Anesth. 2010;19:293–297.
    1. Sillou S, Carbonnel M, N’Doko S, Dhonneur G, Uzan M, Poncelet C. Douleur périnéale du post-partum : intérêt de l’infiltration locale de ropivacaïne. J Gynécologie Obstétrique Biol Reprod. 2009;38:510–515.
    1. Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R, Aass N, Kaasa S, European Palliative Care Research Collaborative (EPCRC) Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manag. 2011;41:1073–1093.
    1. Selo-Ojeme DO, Okonkwo CA, Atuanya C, Ndukwu K. Single-knot versus multiple-knot technique of perineal repair: a randomised controlled trial. Arch Gynecol Obstet. 2016;294:945–952.
    1. Leplège A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998;51:1013–1023.
    1. Gandek B, Sinclair SJ, Kosinski M, Ware JE. Psychometric Evaluation of the SF-36® Health Survey in Medicare Managed Care. Health Care Financ Rev. 2004;25:5–25.
    1. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483.
    1. Seventer R, Vos C, Meerding W, Mear I, Gal M, Bouhassira D. Linguistic validation of the DN4 for use in international studies. Eur J Pain. 2010;14:58–63.
    1. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) Pain. 2005;114:29–36.
    1. Wylomanski S, Bouquin R, Philippe HJ, Poulin Y, Hanf M, Dréno B, Rouzier R, Quéreux G. Psychometric properties of the French Female Sexual Function Index (FSFI) Qual Life Res. 2014;23:2079–2087.
    1. Rosen C, Brown J, Heiman S, Leib R. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208.
    1. Aslan E, Beji NK, Gungor I, Kadioglu A, Dikencik BK. Prevalence and risk factors for low sexual function in women: a study of 1,009 women in an outpatient clinic of a university hospital in Istanbul. J Sex Med. 2008;5:2044–2052.
    1. Teissedre F, Chabrol H. A study of the Edinburgh Postnatal Depression Scale (EPDS) on 859 mothers: detection of mothers at risk for postpartum depression [in French] Encephale. 2004;30:376–381.
    1. Guedeney N, Fermanian J. Validation study of the French version of the Edinburgh Postnatal Depression Scale (EPDS): new results about use and psychometric properties. Eur Psychiatry. 1998;13:83–89.
    1. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry J Ment Sci. 1987;150:782–786.
    1. Sword W, Kurtz Landy C, Thabane L, Watt S, Krueger P, Farine D, Foster G. Is mode of delivery associated with postpartum depression at 6 weeks: a prospective cohort study: mode of delivery and postpartum depression. BJOG Int J Obstet Gynaecol. 2011;118:966–977.
    1. Gaillard A, Le Strat Y, Mandelbrot L, Keïta H, Dubertret C. Predictors of postpartum depression: prospective study of 264 women followed during pregnancy and postpartum. Psychiatry Res. 2014;215:341–346.
    1. Moja LP, Moschetti I, Nurbhai M, et al. Compliance of clinical trial registries with the World Health Organization minimum data set: a survey. Trials. 2009;10:56.
    1. International Committee of Medical Journal Editors Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med. 1997;336:309–315.

Source: PubMed

3
Se inscrever